| dc.contributor.author | Karia, A. | |
| dc.contributor.author | Kravitz, L. | |
| dc.contributor.author | Shah, C. | |
| dc.date.accessioned | 2010-06-14T13:58:48Z | |
| dc.date.available | 2010-06-14T13:58:48Z | |
| dc.date.issued | 2010-04 | |
| dc.identifier.citation | Karia , A , Kravitz , L & Shah , C 2010 , ' Schizophrenia: helping patients adhere to long-term management plans ' , Chemist and Druggist , vol. 1523 , pp. 17-21 . | |
| dc.identifier.issn | 0009-3033 | |
| dc.identifier.other | dspace: 2299/4572 | |
| dc.identifier.uri | http://hdl.handle.net/2299/4572 | |
| dc.description | Original article can be found at: http://www.chemistanddruggist.co.uk/ | |
| dc.description.abstract | Schizophrenia affects around one in every 100 people during their lifetime. First symptoms are typically experienced between the ages of 15 and 35, and the disease affects men and women equally. Incidence is higher in cities, and in migrant and ethnic minority groups. Schizophrenia is a psychiatric disorder that alters an individual’s perception, thoughts, affect and behaviour. It can often be distressing for individuals and their family, and can influence their personal, social and occupational lives. Early and accurate diagnosis, intervention and the selection of effective treatment(s) are paramount in improving quality of life. | en |
| dc.format.extent | 886430 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Chemist and Druggist | |
| dc.title | Schizophrenia: helping patients adhere to long-term management plans | en |
| dc.contributor.institution | Department of Pharmacy | |
| dc.description.status | Peer reviewed | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
